These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1986724)

  • 1. The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis.
    Kissel JT; Halterman RK; Rammohan KW; Mendell JR
    Arch Neurol; 1991 Jan; 48(1):26-30. PubMed ID: 1986724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvascular alterations and the role of complement in dermatomyositis.
    Lahoria R; Selcen D; Engel AG
    Brain; 2016 Jul; 139(Pt 7):1891-903. PubMed ID: 27190020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvascular deposition of complement membrane attack complex in dermatomyositis.
    Kissel JT; Mendell JR; Rammohan KW
    N Engl J Med; 1986 Feb; 314(6):329-34. PubMed ID: 3945256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C5b-9 deposits on endomysial capillaries in non-dermatomyositis cases.
    Braczynski AK; Harter PN; Zeiner PS; Drott U; Tews DS; Preusse C; Penski C; Dunst M; Weis J; Stenzel W; Mittelbronn M
    Neuromuscul Disord; 2016; 26(4-5):283-91. PubMed ID: 27020463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane attack complex deposits in cutaneous lesions of dermatomyositis.
    Mascaró JM; Hausmann G; Herrero C; Grau JM; Cid MC; Palou J; Mascaró JM
    Arch Dermatol; 1995 Dec; 131(12):1386-92. PubMed ID: 7492126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular changes in early and advanced dermatomyositis: a quantitative study.
    Emslie-Smith AM; Engel AG
    Ann Neurol; 1990 Apr; 27(4):343-56. PubMed ID: 2353792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early ultrastructural alterations in adult dermatomyositis. Capillary abnormalities precede other structural changes in muscle.
    De Visser M; Emslie-Smith AM; Engel AG
    J Neurol Sci; 1989 Dec; 94(1-3):181-92. PubMed ID: 2614466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic significance of membrane attack complex and vitronectin in childhood dermatomyositis.
    Sakuta R; Murakami N; Jin Y; Nagai T; Nonaka I; Nishino I
    J Child Neurol; 2005 Jul; 20(7):597-602. PubMed ID: 16159528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular pathology in dermatomyositis and anatomic relations to myopathology.
    Pestronk A; Schmidt RE; Choksi R
    Muscle Nerve; 2010 Jul; 42(1):53-61. PubMed ID: 20544925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.
    Basta M; Dalakas MC
    J Clin Invest; 1994 Nov; 94(5):1729-35. PubMed ID: 7962520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.
    Gherardi RK
    Presse Med; 2011 Apr; 40(4 Pt 2):e209-18. PubMed ID: 21376512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistological analysis of CD59 and membrane attack complex of complement in muscle in juvenile dermatomyositis.
    Gonçalves FG; Chimelli L; Sallum AM; Marie SK; Kiss MH; Ferriani VP
    J Rheumatol; 2002 Jun; 29(6):1301-7. PubMed ID: 12064850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcoplasmic MxA expression: A valuable marker of dermatomyositis.
    Uruha A; Nishikawa A; Tsuburaya RS; Hamanaka K; Kuwana M; Watanabe Y; Suzuki S; Suzuki N; Nishino I
    Neurology; 2017 Jan; 88(5):493-500. PubMed ID: 28039312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvascular changes in skeletal muscle in idiopathic inflammatory myopathy.
    Estruch R; Grau JM; Fernández-Solá J; Casademont J; Monforte R; Urbano-Márquez A
    Hum Pathol; 1992 Aug; 23(8):888-95. PubMed ID: 1644434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncertainties in the pathogenesis of adult dermatomyositis.
    Greenberg SA; Amato AA
    Curr Opin Neurol; 2004 Jun; 17(3):359-64. PubMed ID: 15167072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunopathogenic role of complement in human muscle disease.
    Mendell JR; Garcha TS; Kissel JT
    Curr Opin Neurol; 1996 Jun; 9(3):226-34. PubMed ID: 8839617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis.
    Preuße C; Allenbach Y; Hoffmann O; Goebel HH; Pehl D; Radke J; Doeser A; Schneider U; Alten RH; Kallinich T; Benveniste O; von Moers A; Schoser B; Schara U; Stenzel W
    Acta Neuropathol Commun; 2016 Apr; 4(1):45. PubMed ID: 27121733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Animal experiment and biopsy studies on the cause, manifestations and diagnostic relevance of perifascicular muscle fiber atrophy].
    Herrmann V
    Z Gesamte Inn Med; 1985 Jul; 40(14):417-23. PubMed ID: 2931906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis.
    Crowe WE; Bove KE; Levinson JE; Hilton PK
    Arthritis Rheum; 1982 Feb; 25(2):126-39. PubMed ID: 7066042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vascular manifestations of dermatomyositis and polymyositis. Clinical, capillaroscopic and histological aspects].
    Leteurtre E; Hachulla E; Janin A; Hatron PY; Brouillard M; Devulder B
    Rev Med Interne; 1994; 15(12):800-7. PubMed ID: 7863114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.